p53 polymorphism, human papillomavirus infection in the oral cavity, and oral cancer

被引:57
作者
Summersgill, KF
Smith, EM
Kirchner, HL
Haugen, TH
Turek, LP
机构
[1] Univ Iowa, Dept Oral Pathol Radiol & Med, Coll Dent, Iowa City, IA 52242 USA
[2] Univ Iowa, Coll Publ Hlth, Dept Epidemiol, Iowa City, IA 52242 USA
[3] Univ Iowa, Coll Publ Hlth, Dept Biostat, Iowa City, IA 52242 USA
[4] Univ Iowa, Coll Med, Iowa City, IA 52242 USA
[5] Vet Affairs Med Ctr, Dept Pathol, Iowa City, IA 52242 USA
来源
ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTOLOGY | 2000年 / 90卷 / 03期
关键词
D O I
10.1067/moe.2000.107359
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Objectives. Human papillomavirus (HPV) infection has emerged as a risk factor in oral carcinogenesis. An arginine-coding polymorphism of the tumor suppressor protein p53 at codon 72 is more readily degraded by the HPV oncoprotein EG. Our objective was to evaluate the association between p53 polymorphism at codon 72 and HPV infection In the oral cavity, as well as its association with oral cancer. Study design. Oral squamous cells from 202 patients with oral cancer and 333 age-sex frequency matched controls were evaluated by polymerase chain reaction for the presence and type of HPV and for alleles of codon 72 in p53. Fisher exact test and chi(2) tests were used to evaluate the data, Results, The p53 codon 72 polymorphism is not associated with HPV infection, whether comparing HPV-negative controls with HPV-positive controls or comparing HPV-negative cases with HPV-positive cases. Additionally, we round no association with the codon 72 polymorphism and oral cancer, whether comparing HPV-negative controls with HPV-negative cases or comparing HPV-positive controls with HPV-positive cases. Conclusions. There is no association between p53 codon 72 polymorphism and HPV infection or between the p53 polymorphism and the risk of oral cancer.
引用
收藏
页码:334 / 339
页数:6
相关论文
共 62 条
  • [11] CHEBAB FF, 1987, NATURE, V329, P678
  • [12] DETECTION OF SICKLE-CELL-ANEMIA AND THALASSEMIAS
    CHEHAB, FF
    DOHERTY, M
    CAI, S
    KAN, YW
    COOPER, S
    RUBIN, EM
    [J]. NATURE, 1987, 329 (6137) : 293 - 294
  • [13] DELACALLEMARTIN O, 1990, NUCLEIC ACIDS RES, V18, P4963, DOI 10.1093/nar/18.16.4963-a
  • [14] THE HUMAN PAPILLOMA VIRUS-16 E7-ONCOPROTEIN IS ABLE TO BIND TO THE RETINOBLASTOMA GENE-PRODUCT
    DYSON, N
    HOWLEY, PM
    MUNGER, K
    HARLOW, E
    [J]. SCIENCE, 1989, 243 (4893) : 934 - 937
  • [15] Giannoudis A, 1999, INT J CANCER, V83, P66, DOI 10.1002/(SICI)1097-0215(19990924)83:1<66::AID-IJC13>3.0.CO
  • [16] 2-K
  • [17] Interferon-alpha and p53 alleles involved in nasopharyngeal carcinoma
    Golovleva, I
    Birgander, R
    Sjalander, A
    Lundgren, E
    Beckman, L
    [J]. CARCINOGENESIS, 1997, 18 (04) : 645 - 647
  • [18] Homozygous arginine-72 in wild type p53 and risk of cervical cancer
    Hayes, VM
    Hofstra, RMW
    Buys, CHCM
    Hollema, H
    van der Zee, AGJ
    [J]. LANCET, 1998, 352 (9142) : 1756 - 1756
  • [19] Helland Å, 1998, NATURE, V396, P530, DOI 10.1038/25034
  • [20] PERSISTENCE OF TYPE-SPECIFIC HUMAN PAPILLOMAVIRUS INFECTION AMONG CYTOLOGICALLY NORMAL WOMEN
    HILDESHEIM, A
    SCHIFFMAN, MH
    GRAVITT, PE
    GLASS, AG
    GREER, CE
    ZHANG, T
    SCOTT, DR
    RUSH, BB
    LAWLER, P
    SHERMAN, ME
    KURMAN, RJ
    MANES, MM
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1994, 169 (02) : 235 - 240